Pennant Investors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,500
Closed -$190K 41
2024
Q2
$190K Hold
17,500
0.05% 37
2024
Q1
$328K Hold
17,500
0.08% 32
2023
Q4
$379K Buy
+17,500
New +$379K 0.08% 29